Latest Operational Leadership News

PYC Therapeutics has restructured its Board and executive team to steer the company through pivotal clinical milestones expected by the end of 2027. The changes signal a strategic push toward late-stage development of its RNA-based drug candidates.

Bubs Australia has appointed Paul Jensen as its new Independent Chair and Joe Coote as Managing Director and CEO, signaling a fresh leadership chapter for the infant formula and dairy company.

Theta Gold Mines has officially begun construction at its flagship TGME Gold Mine in South Africa, securing key contracts and funding support that pave the way for production by early 2027.

Spenda Limited announces the resignation of CEO Adrian Floate due to health concerns, appointing COO Corrie Hassan as interim CEO and welcoming Francis DeSouza to the Board. The company aims to maintain momentum following a record revenue year.

Shareholders of Washington H. Soul Pattinson and Brickworks have overwhelmingly approved their respective share schemes, paving the way for a major merger and new leadership incentives.

Advanced Braking Technology has appointed CEO Andrew Booth to the Board as Managing Director, signaling confidence in his leadership amid ongoing growth.

Green360 Technologies announces CEO Bojan Bogunovic's resignation effective October 31, with Executive Chairman Aaron Banks stepping in to lead daily operations during a pivotal growth phase.

Collins Foods delivered record $1.5 billion revenue in FY25, pivoting to focus on KFC growth in Australia and Germany while exiting Taco Bell. Despite impairments and wage remediation costs, the company targets strong profit growth in FY26.

3P Learning reported a 30% rise in underlying EBITDA to $15.5 million for FY25, alongside a return to statutory profitability and a key acquisition to strengthen its literacy offerings.

Apiam Animal Health posted modest FY25 growth amid challenges in clinical services, launching a Strategic Reset Program and attracting an acquisition proposal from Adamantem Capital.

Botala Energy has raised A$1.5 million through a discounted share placement to fund critical drilling and feasibility work at its Serowe CBM Project in Botswana. Directors and the CEO are backing the raise, signaling confidence in the project’s potential.

Anteris Technologies reported solid clinical progress with 130 patients implanted with its DurAVR heart valve and is gearing up for its pivotal PARADIGM trial with 79 qualified sites worldwide. The company also strengthened its leadership with two new board members amid ongoing FDA engagement.